Rhythm Pharmaceuticals is a global, commercial-stage biopharmaceutical company focused on transforming the lives of patients with rare neuroendocrine diseases by rapidly advancing care and precision medicines that address the root cause. The Company develops medicines for previously untreatable or undertreated diseases and provides meaningful support for healthcare providers and patients and their families. In addition to commercializing its lead asset in North America, Europe and other regions, Rhythm is advancing a broad clinical development program in rare MC4R pathway diseases, as well as investigational MC4R agonists, and a preclinical suite of small molecules for the treatment of congenital hyperinsulinism. At Rhythm, we know our work makes an important difference in the lives of patients and their families around the world. Every employee contributes to the company’s goal of discovering new treatments for rare diseases that no other company is developing. As a fast-growing company with an exciting future, we offer a collaborative environment where employees’ contributions truly matter, which is one of the many reasons we were recognized as one of The Boston Globe’s Top Places to Work in Massachusetts for 2023 and 2024.
| Website | http://www.rhythmtx.com |
| Ticker | RYTM |
| Revenue | $130.1 million |
| Funding | $698.5 million |
| Employees | 438 (330 on RocketReach) |
| Founded | 2008 |
| Address | 222 Berkeley Street 12th Floor, Boston, Massachusetts 02116, US |
| Phone | (857) 264-4280 |
| Fax | (857) 264-4299 |
| Technologies |
JavaScript
,
HTML
,
PHP
+33 more
(view full list)
|
| Industry | Biotechnology Research, Pharmaceuticals, Healthcare |
| Keywords | Genetic Disease Research, Peptide Therapeutics, Pituitary Disorders, Clinical Stage Biopharma, Drug Discovery Platform, Regulatory Affairs, Clinical Trial Data |
| Competitors | Pfizer, Boehringer Ingelheim, Amgen, Bristol Myers Squibb, AstraZeneca, Novo Nordisk, Genentech, Sanofi, Merck AH, Lilly India +43 more (view full list) |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 32 Companies, NAICS Code 325413 Companies, NAICS Code 325 Companies, NAICS Code 32541 Companies, NAICS Code 3254 Companies |
Looking for a particular Rhythm Pharmaceuticals Inc. employee's phone or email?
The Rhythm Pharmaceuticals Inc. annual revenue was $130.1 million in 2026.
Hunter Smith is the CFO of Rhythm Pharmaceuticals Inc..
330 people are employed at Rhythm Pharmaceuticals Inc..
Rhythm Pharmaceuticals Inc. is based in Boston, Massachusetts.
The NAICS codes for Rhythm Pharmaceuticals Inc. are [32, 325413, 325, 32541, 3254].
The SIC codes for Rhythm Pharmaceuticals Inc. are [283, 28].